, May 22, 2014
/PRNewswire/ -- Bayer, the global health care, agriculture and high-tech polymer materials company, received the U.S.-based Foreign Policy Association's (FPA) 2014 Corporate Social Responsibility Award at the FPA's 95th
annual dinner in New York City
on May 21
Dr. Marijn Dekkers, Bayer's Chairman and CEO, accepted the award honoring Bayer's good corporate citizenship as demonstrated by the many ways and extent to which the company gives back to the communities where it does business. Dr. Mae Jemison, scientist, educator and the country's first African American female astronaut, presented the award to Dr. Dekkers. Dr. Jemison has served as national spokesperson for Bayer's award-winning Making Science Make Sense® companywide initiative since 1995.
Through its three foundations the Bayer Science & Education Foundation, the Bayer Cares Foundation and the Bayer USA Foundation, Bayer provided some 50 million for these activities in 2013. As with its business operations, Bayer's social commitment is based on innovation and pioneering spirit.
"Bayer's overarching goal is to help more and more people live a better life, and our science helps us to continuously innovate to support this goal," Dr. Dekkers said. "We share the FPA's goal to develop awareness, understanding and informed opinion on critical issues happening in the world today. We thank the FPA for this special honor, which recognizes the tireless work of our employees on corporate social responsibility activities worldwide."
In the United States, Bayer Corporation and the Bayer USA Foundation partner with local community leaders to provide philanthropic support to organizations and programs centered on education and workforce development, health and human services, and the environment and sustainability.
Bayer aligns the Foundation's philanthropic work with its significant investments in STEM (science, technology, engineering and mathematics) education and Making Science Make Sense, as well as patient advocacy, disaster relief, diversity and inclusion, among others.
Bayer was one of three companies named by FPA as a 2014 CSR Award recipient. Viacom Inc. and John Hancock Financial Services also received awards.
Social Media Users:
About Bayer Corporation and Making Science Make Sense®
Bayer Corporation is a subsidiary of Bayer AG, a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an inventor company, Bayer sets trends in research-intensive areas. Bayer products and services are designed to benefit people and improve the quality of life. At the same time, Bayer aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal 2013, Bayer employed 113,200 people at year-end and had sales of 40.2 billion. In North America, Bayer had 2013 net sales of 9,680 million ($12,874 million) and employed 15,200 at year-end. For more information, go to www.bayerus.com.
Making Science Make Sense® (MSMS) is Bayer's company-wide initiative that advances science literacy through hands-on, inquiry-based science education, employee volunteerism and a public education campaign. Currently, 12 Bayer sites around the U.S. operate local MSMS programs, which together represent a national volunteer corps of more than 1,000 employees. For more information, go to www.bayerus.com/msms.
About Bayer USA Foundation
The Bayer USA Foundation is an endowed 501(c)(3) entity with a programmatic focus on education and workforce development, and environment and sustainability. The Foundation supports organizations that enhance quality of life, connect diverse groups, ensure preparedness for tomorrow's leaders, and improve communities in which Bayer employees live and work. The Bayer USA Foundation is one of three Bayer foundations worldwide, including the Bayer Science & Education Foundation and the Bayer Cares Foundation. To learn more, go to bayerus.com/foundation.
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
SOURCE Bayer Corporation